Cambridge partners with the University of Strathclyde to develop ‘Digital twins’ – exact computer models of patients – to enhance cancer patients’ recovery times following surgery.
It is with great sadness that we announce the death of Charles Massie, Early Cancer Institute Group Leader, after a long battle with cancer, on 5 May 2023, at the age of 45.
The Cambridge team behind Cytosponge – the 'sponge on a string' which identifies people at risk of oesophageal cancer – is expanding its work in the UK and beyond following a £13.4 million investment.
International Clinical Trials Day, celebrated on 20 May 2023, provides an opportunity to celebrate and acknowledge the invaluable contributions of our research team in the field of cancer research.
For International Nurses Day on Friday 12 May, we highlight the valuable contribution of our research nurses and the importance of continued professional development in their career.
Congratulations to two Centre members on being elected as Fellows of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence.
More than 140 brain cancer patients have benefitted from a landmark NHS testing and treatment programme being trialled at Addenbrooke's, using the latest innovations in genomics and cancer research.